Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study
Rapid identification of rifampicin resistance targeting the high-risk populations, such as younger generations, foreign-born individuals, and previously treated patients are necessary for patient-centered care.
Authors
- Doosoo Jeon (ORCID: https://orcid.org/0000-0002-8206-9487)
- Jinsoo Min (ORCID: https://orcid.org/0000-0001-6091-518X)
- Taehoon Lee (ORCID: https://orcid.org/0000-0002-9224-0866)
- Jee Youn Oh (ORCID: https://orcid.org/0000-0002-1219-0070)
- Jae Seuk Park (ORCID: https://orcid.org/0000-0001-9307-1155)
- Yousang Ko (ORCID: https://orcid.org/0000-0002-1703-6590)
- Hyeon‐Kyoung Koo (ORCID: https://orcid.org/0000-0002-1200-9892)
- Hyung Woo Kim (ORCID: https://orcid.org/0000-0002-6305-452X)
- Sung Chul Lim
- Ju Sang Kim
- Young-Chul Kim
- Sung Soon Lee
Institutions
- Chonnam National University (KR)
- Ulsan College (KR)
- Hallym University (KR)
- Korea University Medical Center (KR)
- Sacred Heart Hospital (IE)
- University of Ulsan (KR)
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- Inje University Ilsan Paik Hospital (KR)
- Ulsan University Hospital (KR)
- Kangdong Sacred Heart Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
- Dankook University (KR)
Publication Details
- Journal
- Tuberculosis & respiratory diseases
- Published
- 2024-09-23
- DOI
- https://doi.org/10.4046/trd.2024.0049
- Citations
- 7
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- Korea Disease Control and Prevention Agency